greeksoup/ stock research

Sensient Technologies Corp.: Q3 FY2025 earnings call

What management said about Q3 FY2025, from the documents filed with the SEC on 31 October 2025: press release. Guidance figures: 3 raised, 2 kept. The quarter’s numbers.

Key takeaways

  • Revenue rose 5.0% in quarter: Reported revenue rose 5.0% to $412.1 million from $392.6 million. Local currency revenue rose 3.5%, with currency adding 1.5 points. Source
  • Operating income up 14.2%: Reported operating income rose 14.2% to $57.7 million from $50.5 million in the prior year's third quarter. Source
  • Diluted EPS rose to 87 cents: Reported diluted EPS was 87 cents against 77 cents, up 13.0%. Local currency adjusted diluted EPS rose 17.5%. Source
  • Color revenue and profit rose: Color revenue rose 9.9% to $178.2 million, and segment operating income rose $7.9 million to $37.7 million. Source
  • Agricultural ingredients volumes declined: Lower volumes in agricultural ingredients, formerly reported as natural ingredients, reduced Flavors & Extracts revenue. Source
  • Adjusted EBITDA rose 16.3%: Adjusted EBITDA rose 16.3% to $80.5 million from $69.3 million, and 14.3% in local currency. Source

“Sensient’s dedication to customer service while continuing to innovate and drive new sales wins has resulted in strong results.”

Paul Manning, Sensient’s Chairman, President, and Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Local currency revenue growth Source2025 full yearMid-Single-Digit GrowthKept
Local currency adjusted EBITDA growth Source2025 full yearDouble-Digit GrowthRaised from High Single-Digit Growth
Diluted EPS (GAAP) Source2025 full yearBetween $3.13 and $3.23Kept
Portfolio Optimization Plan costs included in EPS guidance Source2025 full yearapproximately 28 centsRaised from approximately 20 cents
Local currency adjusted diluted EPS growth Source2025 full yearDouble-Digit GrowthRaised from High Single-Digit to Double-Digit Growth

What changed from last quarter

  • Guidance raised: Local currency adjusted EBITDA growth guidance raised to double-digit from high single-digit. Source
  • Guidance raised: Local currency adjusted diluted EPS growth now given as double-digit, previously high single-digit to double-digit. Source
  • Guidance raised: Portfolio Optimization Plan costs included in the GAAP EPS guidance rose to approximately 28 cents from approximately 20 cents. Source
  • Guidance kept: Revenue guidance and GAAP diluted EPS guidance unchanged from the prior release. Source
  • New: Natural ingredients product line is now reported as agricultural ingredients. Source

Consolidated results and growth

  • Revenue rose 5.0% in quarter: Reported revenue rose 5.0% to $412.1 million from $392.6 million. Local currency revenue rose 3.5%, with currency adding 1.5 points. Source
  • Operating income up 14.2%: Reported operating income rose 14.2% to $57.7 million from $50.5 million in the prior year's third quarter. Source
  • Diluted EPS rose to 87 cents: Reported diluted EPS was 87 cents against 77 cents, up 13.0%. Local currency adjusted diluted EPS rose 17.5%. Source
  • Nine-month earnings grew: Nine-month net earnings rose 15.3% to $109.0 million, and nine-month diluted EPS was $2.56 against $2.23. Source

Segment and regional results

  • Color revenue and profit rose: Color revenue rose 9.9% to $178.2 million, and segment operating income rose $7.9 million to $37.7 million. Source
  • Flavors & Extracts revenue edged lower: Flavors & Extracts revenue fell $0.3 million to $203.0 million, while segment operating income rose $2.2 million to $28.0 million. Source
  • Asia Pacific revenue and profit edged up: Asia Pacific revenue rose $0.3 million to $42.1 million, and segment operating income rose $0.2 million to $9.5 million. Source

“I remain very confident about our performance and am excited about the opportunities in front of us, particularly in natural colors,”

Paul Manning, Sensient’s Chairman, President, and Chief Executive Officer

Product lines and drivers

  • Agricultural ingredients volumes declined: Lower volumes in agricultural ingredients, formerly reported as natural ingredients, reduced Flavors & Extracts revenue. Source
  • Higher prices partly offset decline: Higher prices and volumes in flavors, extracts, and flavor ingredients partly offset the agricultural ingredients decline. Source
  • Color growth from food and pharma: Color revenue growth came from higher prices and volume growth in the food and pharmaceutical product lines. Source

Costs and plan spending

  • Corporate costs rose to $17.6 million: Corporate & Other operating expenses rose to $17.6 million from $14.5 million, primarily due to higher Portfolio Optimization Plan costs in the quarter. Source
  • Performance pay lifted corporate costs: Local currency adjusted Corporate & Other operating expenses rose $1.0 million, primarily from higher performance-based compensation costs recorded in 2025. Source
  • Cost of products sold rose: Cost of products sold rose 3.3% to $270.8 million, and selling and administrative expenses rose 4.7% to $83.6 million. Source
  • Plan costs $3.3 million in quarter: Portfolio Optimization Plan costs were $3.3 million in the quarter against $1.2 million a year earlier, and $9.5 million for the nine months. Source

Adjusted profit measures

  • Adjusted operating income up 18.0%: Adjusted operating income rose 18.0% to $61.0 million from $51.7 million; local currency growth was 15.7%. Source
  • Adjusted EBITDA rose 16.3%: Adjusted EBITDA rose 16.3% to $80.5 million from $69.3 million, and 14.3% in local currency. Source
  • Adjusted net earnings up 20.8%: Adjusted net earnings rose 20.8% to $40.9 million from $33.9 million. Source
  • Share-based compensation rose: Share-based compensation expense was $3.9 million in the quarter against $2.1 million, and is added back in adjusted EBITDA. Source
  • Non-GAAP measures exclude plan costs: Adjusted measures exclude currency movements, depreciation and amortization, Portfolio Optimization Plan costs, and non-cash share-based compensation. Source

Cash, debt and shareholder returns

  • Operating cash flow fell: Net cash provided by operating activities was $83.3 million for the nine months, against $135.8 million a year earlier. Source
  • Capital spending increased: Spending on property, plant, and equipment rose to $57.8 million for the nine months from $36.1 million. Source
  • Dividends held at $1.23 a share: Dividends paid were $52.2 million for the nine months, and dividends per share were $1.23 in both years. Source
  • Net debt ratio eased to 2.3x: Net debt was $684.0 million, and net debt to credit adjusted EBITDA was 2.3 times against 2.4 times a year earlier. Source
  • Cash balance rose: Cash and cash equivalents were $42.7 million at September 30, 2025, up from $26.6 million at December 31, 2024. Source

Risks management discussed

  • Demand: Lower volumes in agricultural ingredients reduced Flavors & Extracts revenue during the quarter. Source
  • Financial: Higher Portfolio Optimization Plan costs were the primary reason Corporate & Other operating expenses increased. Source

Earlier plans management reported on

  • Not stated: The release refers to Portfolio Optimization Plan costs recorded in the quarter, with no timing or completion status given. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.